Law360, New York (October 15, 2007, 12:00 AM EDT) -- Medtronic Inc. announced Monday that it will no longer sell an electrical lead used in its implantable defibrillators because it may be prone to fracturing and has been identified as a possible factor in five deaths, though it does not recommended removing leads that have already been implanted.
The company has stopped selling its Sprint Fidelis lead, a component used to connect an implantable defibrillator to a patient's heart, and has recommended that doctors stop using them. When a lead fractures, it can cause the defibrillator...
Medtronic Stops Sales Of Defibrillator Part
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
